Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Fatema Khambati"'
Autor:
Shari Pilon-Thomas, Jad Chahoud, Matthew Beatty, Michael I Carter, Fatema Khambati, Marine Potez, Mohammed Alkhouli, Johannes Ali
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/723a11eadc254cd386180b4bbb901855
Autor:
Amy Hall, Shari Pilon-Thomas, MacLean Hall, Jason Fleming, Jamie Teer, Matthew Beatty, Larissa Pikor, Barbara Sennino, Madeline Rodriguez-Valentin, Timothy J Langer, Fatema Khambati
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/a3b13e597267498b833d4023d5d31f5b
Autor:
Roohi Ismail-Khan, Marilyn M. Bui, Hatem Soliman, Hyo S. Han, Scott J. Antonia, Daniel M. Sullivan, Fatema Khambati
Publikováno v:
Oncotarget
// Hatem Soliman 1, 2 , Fatema Khambati 2 , Hyo S. Han 1 , Roohi Ismail-Khan 1 , Marilyn M. Bui 3 , Daniel M. Sullivan 4 and Scott Antonia 2, 5 1 Breast Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA 2 Immunology Depa
Publikováno v:
Cancer Research. 80:1011-1011
TANK binding kinase 1 (TBK1) is a non-canonical IκB kinase that regulates the innate immune response and is highly expressed in lung, breast, pancreatic and colon cancers. It phosphorylates and activates downstream targets such as IRF3 and c-Rel and
Autor:
David Noyes, Scott J. Antonia, Richard Lush, Anthony Neuger, Mario R. Mautino, Hatem Soliman, Hyo S. Han, Alberto Chiappori, John D. Roberts, Charles J. Link, Howard Streicher, Nicholas N. Vahanian, Fatema Khambati, Daniel M. Sullivan, Roohi Ismail-Khan, Susan Minton
Publikováno v:
Oncotarget
// hatem h. soliman 1 , susan e. minton 1 , hyo sook han 1 , roohi ismail-khan 1 , anthony neuger 1 , fatema khambati 1 , david noyes 1 , richard lush 1 , alberto a. chiappori 1 , john d. roberts 2 , charles link 3 , nicholas n. vahanian 3 , mario ma
Autor:
Fatema Khambati, Hatem Soliman
Publikováno v:
Cancer Research. 79:2395-2395
Background: Immunotherapies involving cytotoxic T lymphocytes (CTL’s) have been central to cancer immunotherapy. Bi-specific T cell engager antibody (BiTE) therapy has emerged as an effective immunotherapy by redirecting cytotoxic T cells against c
Publikováno v:
Cancer Research. 78:4701-4701
Background: Programmed death ligand 1 (PDL1) is commonly expressed on the surface of many tumor cells, including breast cancer. The activity of tumor-infiltrating lymphocytes (TIL) is inhibited by PDL1. High PD-L1 basal cells (particularly basal B) o
Autor:
Vivek V. Pai, Fatema Khambati, Ramaswamy Ganapati, Sunil Dattatraya Ghate, Gospi Dolly Capadia, Shetty Vp
Publikováno v:
Leprosy Review. 81:41-58
Objective: To investigate effects of therapeutic usage of corticosteroids on M. leprae killing and clearance, on clearance of granuloma and on nerve damage in multibacillary (MB) leprosy patients. Design: From a cohort of 400 untreated MB patients, a
Publikováno v:
Leprosy Review. 80:34-50
Summary Objective To determine sensitivity and specificity of clinical tools viz. nerve palpation (NP), monofilament (MF), and voluntary muscle testing (VMT), for assessing peripheral nerve function impairment (NFI) in leprosy, using nerve conduction
Autor:
Shetty Vp, Sunil Dattatraya Ghate, Gospi Dolly Capadia, Vivek V. Pai, Fatema Khambati, Ramaswamy Ganapati
Publikováno v:
Leprosy Review. 79:134-153
Summary Objective To investigate possible adverse effects of therapeutic usage of corticosteroids on the killing and clearance of M. leprae and the clearance of granuloma, in patients with multibacillary (MB) leprosy. Design A cohort of 400 untreated